30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Titan Spine Raises Capital to Support nanoLOCK Interbody Fusion Devices -

Titan Spine closed a substantial round of financing for an undisclosed amount with its investor, Southlake Equity. Proceeds will support U.S. sales expansion and surgeon adoption of Endoskeleton® titanium interbody fusion implants and launch of next-generation nanoLOCK™ surface technology.

The company just announced the creation of a new technology ICD-10 code for a nanotextured surface on an interbody fusion device. Titan Spine’s nanoLOCK technology has been given access to use this code, beginning 4Q16.

Sources: Titan Spine LLC, ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.